Skip to main content

Animations

MJFF Publications

6341 - 6350 of 6433 Results
Title
Year
  • Year
  • 2019
  • 2025
  • 2020
  • 2016
  • 2017
  • 2017
  • 2020
  • 2017
  • 2021
  • 2011
  • Summary Details
    OPEN
    Title: Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection
    Journal Name: Cell Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41422-019-0153-8
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Personalised regional modelling predicts tau progression in the human brain
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3003241
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28338
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Weighted Protein Interaction Network Analysis of Frontotemporal Dementia
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.6b00934
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2016.12.011
    Citation Count: 381
  • Summary Details
    OPEN
    Title: An invisible ubiquitin conformation is required for efficient phosphorylation by PINK 1
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embj.201797876
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.01.017
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-017-0153-4
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/nan.12728
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Group patient visits for Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182194bad
    Citation Count: 22
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.